NORWOOD IMMUNOLOGY -- INTENTION TO SEEK INITIAL PUBLIC OFFERING IN THE USA

Medical technologies group Norwood Abbey Ltd advises that its subsidiary Norwood Immunology Limited (AIM: NIM), the company focussed on the rejuvenation of the immune system, today announces its intention, subject to market conditions, to seek an initial public offering of its shares in the USA. The Company is in the process of appointing a US based investment banking firm in connection with this planned public offering.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/ed583e3b5c6a1ea2dcf9cc55493e9d34.html)